• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鉴定乳腺癌中新型耗竭 T 细胞 CD8+标志物。

Identification of the novel exhausted T cell CD8 + markers in breast cancer.

机构信息

Cancer Research Institute, Jinan University, Guangzhou, China.

Havergal College, Toronto, Canada.

出版信息

Sci Rep. 2024 Aug 19;14(1):19142. doi: 10.1038/s41598-024-70184-1.

DOI:10.1038/s41598-024-70184-1
PMID:39160211
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11333736/
Abstract

Cancer is one of the most concerning public health issues and breast cancer is one of the most common cancers in the world. The immune cells within the tumor microenvironment regulate cancer development. In this study, single immune cell data sets were used to identify marker gene sets for exhausted CD8 + T cells (CD8Tex) in breast cancer. Machine learning methods were used to cluster subtypes and establish the prognostic models with breast cancer bulk data using the gene sets to evaluate the impacts of CD8Tex. We analyzed breast cancer overexpressing and survival-associated marker genes and identified CD8Tex hub genes in the protein-protein-interaction network. The relevance of the hub genes for CD8 + T-cells in breast cancer was evaluated. The clinical associations of the hub genes were analyzed using bulk sequencing data and spatial sequencing data. The pan-cancer expression, survival, and immune association of the hub genes were analyzed. We identified biomarker gene sets for CD8Tex in breast cancer. CD8Tex-based subtyping systems and prognostic models performed well in the separation of patients with different immune relevance and survival. CRTAM, CLEC2D, and KLRB1 were identified as CD8Tex hub genes and were demonstrated to have potential clinical relevance and immune therapy impact. This study provides a unique view of the critical CD8Tex hub genes for cancer immune therapy.

摘要

癌症是最受关注的公共卫生问题之一,而乳腺癌是世界上最常见的癌症之一。肿瘤微环境中的免疫细胞调节癌症的发展。在这项研究中,使用单细胞免疫细胞数据集来鉴定乳腺癌中耗尽的 CD8+T 细胞(CD8Tex)的标记基因集。使用基因集使用机器学习方法对乳腺癌批量数据进行聚类亚型和建立预后模型,以评估 CD8Tex 的影响。我们分析了乳腺癌过表达和与生存相关的标记基因,并在蛋白质-蛋白质相互作用网络中鉴定了 CD8Tex 枢纽基因。评估了这些枢纽基因在乳腺癌中 CD8+T 细胞的相关性。使用批量测序数据和空间测序数据分析了枢纽基因的临床相关性。分析了枢纽基因在泛癌中的表达、生存和免疫相关性。我们在乳腺癌中确定了 CD8Tex 的生物标志物基因集。基于 CD8Tex 的亚分型系统和预后模型在分离具有不同免疫相关性和生存的患者方面表现良好。CRTAM、CLEC2D 和 KLRB1 被鉴定为 CD8Tex 枢纽基因,具有潜在的临床相关性和免疫治疗影响。这项研究为癌症免疫治疗的关键 CD8Tex 枢纽基因提供了独特的视角。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef25/11333736/8f325d319484/41598_2024_70184_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef25/11333736/d317606bf4d6/41598_2024_70184_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef25/11333736/f76577ac6f5b/41598_2024_70184_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef25/11333736/f127606fe1c0/41598_2024_70184_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef25/11333736/7bfe0ae87ca2/41598_2024_70184_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef25/11333736/54ee8370b25c/41598_2024_70184_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef25/11333736/ae556786652b/41598_2024_70184_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef25/11333736/865e562e2aaf/41598_2024_70184_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef25/11333736/8f325d319484/41598_2024_70184_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef25/11333736/d317606bf4d6/41598_2024_70184_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef25/11333736/f76577ac6f5b/41598_2024_70184_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef25/11333736/f127606fe1c0/41598_2024_70184_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef25/11333736/7bfe0ae87ca2/41598_2024_70184_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef25/11333736/54ee8370b25c/41598_2024_70184_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef25/11333736/ae556786652b/41598_2024_70184_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef25/11333736/865e562e2aaf/41598_2024_70184_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ef25/11333736/8f325d319484/41598_2024_70184_Fig8_HTML.jpg

相似文献

1
Identification of the novel exhausted T cell CD8 + markers in breast cancer.鉴定乳腺癌中新型耗竭 T 细胞 CD8+标志物。
Sci Rep. 2024 Aug 19;14(1):19142. doi: 10.1038/s41598-024-70184-1.
2
Advanced machine learning unveils CD8 + T cell genetic markers enhancing prognosis and immunotherapy efficacy in breast cancer.先进的机器学习揭示了CD8 + T细胞基因标志物可增强乳腺癌的预后和免疫治疗效果。
BMC Cancer. 2024 Oct 1;24(1):1222. doi: 10.1186/s12885-024-12952-w.
3
Integration of Bioinformatics and Machine Learning to Identify CD8+ T Cell-Related Prognostic Signature to Predict Clinical Outcomes and Treatment Response in Breast Cancer Patients.生物信息学和机器学习的整合,以识别 CD8+T 细胞相关的预后特征,预测乳腺癌患者的临床结局和治疗反应。
Genes (Basel). 2024 Aug 19;15(8):1093. doi: 10.3390/genes15081093.
4
Integration of multiomics analyses reveals unique insights into CD24-mediated immunosuppressive tumor microenvironment of breast cancer.多组学分析的整合为乳腺癌中 CD24 介导的免疫抑制肿瘤微环境提供了独特的见解。
Inflamm Res. 2024 Jun;73(6):1047-1068. doi: 10.1007/s00011-024-01882-9. Epub 2024 Apr 15.
5
Mining immune-related genes with prognostic value in the tumor microenvironment of breast invasive ductal carcinoma.挖掘乳腺浸润性导管癌肿瘤微环境中具有预后价值的免疫相关基因。
Medicine (Baltimore). 2021 Apr 30;100(17):e25715. doi: 10.1097/MD.0000000000025715.
6
Novel immune-related genes in the tumor microenvironment with prognostic value in breast cancer.肿瘤微环境中具有预后价值的新型免疫相关基因在乳腺癌中的研究。
BMC Cancer. 2021 Feb 6;21(1):126. doi: 10.1186/s12885-021-07837-1.
7
Clonality, Antigen Recognition, and Suppression of CD8 T Cells Differentially Affect Prognosis of Breast Cancer Subtypes.克隆性、抗原识别和 CD8 T 细胞抑制对乳腺癌亚型的预后有不同影响。
Clin Cancer Res. 2020 Jan 15;26(2):505-517. doi: 10.1158/1078-0432.CCR-19-0285. Epub 2019 Oct 24.
8
Deciphering the Prognostic Implications of the Components and Signatures in the Immune Microenvironment of Pancreatic Ductal Adenocarcinoma.解析胰腺导管腺癌免疫微环境中各成分和特征的预后意义。
Front Immunol. 2021 Mar 10;12:648917. doi: 10.3389/fimmu.2021.648917. eCollection 2021.
9
CD8 T cell‑related KCTD5 contributes to malignant progression and unfavorable clinical outcome of patients with triple‑negative breast cancer.CD8 T 细胞相关的 KCTD5 促进三阴性乳腺癌患者的恶性进展和不良临床结局。
Mol Med Rep. 2024 Sep;30(3). doi: 10.3892/mmr.2024.13290. Epub 2024 Jul 19.
10
Glycosylphosphatidylinositol anchor biosynthesis pathway-based biomarker identification with machine learning for prognosis and T cell exhaustion status prediction in breast cancer.基于糖基磷脂酰肌醇锚生物合成途径的生物标志物识别,利用机器学习预测乳腺癌的预后和T细胞耗竭状态
Front Immunol. 2024 Jul 2;15:1392940. doi: 10.3389/fimmu.2024.1392940. eCollection 2024.

引用本文的文献

1
Knockdown of circ_0000372 elevates PD-L1 level through sponging miR-488-3p to restrain cell viability, motility and immune escape in gastric cancer.环状RNA_0000372的敲低通过吸附miR-488-3p提高程序性死亡受体配体1水平,从而抑制胃癌细胞的活力、迁移能力和免疫逃逸。
J Mol Histol. 2025 Sep 13;56(5):312. doi: 10.1007/s10735-025-10598-x.
2
C-type lectin-like domain family 2 (CLEC2D) promotes proliferation and migration of breast cancer and serves as a poor prognostic factor.C型凝集素样结构域家族2(CLEC2D)促进乳腺癌的增殖和迁移,并作为一个不良预后因素。
Breast Cancer. 2025 Sep 12. doi: 10.1007/s12282-025-01777-5.
3
FAM49B mediates tumor progression and poor prognosis of gastric cancer through activating PI3K/AKT pathway.

本文引用的文献

1
Mechanisms of sensitivity and resistance to CDK4/CDK6 inhibitors in hormone receptor-positive breast cancer treatment.CDK4/CDK6 抑制剂在激素受体阳性乳腺癌治疗中的敏感性和耐药机制。
Drug Resist Updat. 2024 Sep;76:101103. doi: 10.1016/j.drup.2024.101103. Epub 2024 Jun 25.
2
Cancer treatments: Past, present, and future.癌症治疗:过去、现在和未来。
Cancer Genet. 2024 Aug;286-287:18-24. doi: 10.1016/j.cancergen.2024.06.002. Epub 2024 Jun 17.
3
Half of most frequently mutated genes in breast cancer are expressed differentially between premenopausal and postmenopausal breast cancer patients.
FAM49B通过激活PI3K/AKT信号通路介导胃癌的肿瘤进展和不良预后。
J Mol Histol. 2025 Sep 3;56(5):291. doi: 10.1007/s10735-025-10589-y.
4
Mycn Is Essential for Pubertal Mammary Gland Development and Promotes the Activation of Bcl11b-Maintained Quiescent Stem Cells.Mycn对青春期乳腺发育至关重要,并促进由Bcl11b维持的静止干细胞的激活。
Cells. 2025 Aug 12;14(16):1239. doi: 10.3390/cells14161239.
5
Integrated single-cell and bulk RNA-sequencing data reveal prognosis and therapeutic response in low-grade glioma based on hypoxia-lactylation related genes.整合单细胞和批量RNA测序数据揭示基于缺氧乳酸化相关基因的低级别胶质瘤的预后和治疗反应
Discov Oncol. 2025 Aug 25;16(1):1618. doi: 10.1007/s12672-025-03459-2.
6
Unmasking immune checkpoint resistance in esophageal squamous cell carcinoma: Insights into the tumor microenvironment and biomarker landscape.揭示食管鳞状细胞癌中的免疫检查点耐药性:对肿瘤微环境和生物标志物格局的见解
World J Gastrointest Oncol. 2025 Aug 15;17(8):109489. doi: 10.4251/wjgo.v17.i8.109489.
7
Targeting GABA signaling in the tumor microenvironment: implications for immune cell regulation and immunotherapy resistance.靶向肿瘤微环境中的GABA信号传导:对免疫细胞调节和免疫治疗抗性的影响
Front Immunol. 2025 Aug 5;16:1645718. doi: 10.3389/fimmu.2025.1645718. eCollection 2025.
8
Integrated multi-omics analysis reveals diagnostic biomarkers and therapeutic targets for systemic lupus erythematosus.综合多组学分析揭示系统性红斑狼疮的诊断生物标志物和治疗靶点。
Medicine (Baltimore). 2025 Aug 15;104(33):e42290. doi: 10.1097/MD.0000000000042290.
9
Evaluating the scope and impact of pre-diagnostic manipulative therapy in children and adolescents with osteosarcoma: A retrospective study in Uganda.评估诊断前手法治疗对骨肉瘤儿童和青少年的范围及影响:乌干达的一项回顾性研究。
PLoS One. 2025 Aug 4;20(8):e0329688. doi: 10.1371/journal.pone.0329688. eCollection 2025.
10
Construction of an immune prediction model for osteosarcoma based on coagulation-related genes.基于凝血相关基因构建骨肉瘤免疫预测模型
Discov Oncol. 2025 Jul 31;16(1):1449. doi: 10.1007/s12672-025-03214-7.
乳腺癌中大多数经常发生突变的基因有一半在绝经前和绝经后乳腺癌患者之间的表达存在差异。
Cancer Genet. 2024 Aug;286-287:11-17. doi: 10.1016/j.cancergen.2024.06.001. Epub 2024 Jun 13.
4
Clinical management of TP53 mosaic variants found on germline genetic testing.生殖系基因检测中发现的TP53镶嵌变异体的临床管理。
Cancer Genet. 2024 Jun;284-285:43-47. doi: 10.1016/j.cancergen.2024.04.002. Epub 2024 Apr 23.
5
Low expression of predicts poor survival outcomes and is associated with immune infiltration in breast cancer.[具体指标]的低表达预示着乳腺癌患者预后不良,并与免疫浸润相关。 (这里原文中“Low expression of ”后面缺少具体内容,所以翻译时用“[具体指标]”代替)
Transl Cancer Res. 2024 Mar 31;13(3):1225-1240. doi: 10.21037/tcr-23-1231. Epub 2024 Mar 25.
6
1,3,6-Trigalloylglucose: A Novel Potent Anti- Adhesion Agent Derived from Aqueous Extracts of Retz.1,3,6-三没食子酰葡萄糖:一种源自Retz.水提取物的新型强效抗黏附剂
Molecules. 2024 Mar 5;29(5):1161. doi: 10.3390/molecules29051161.
7
CRTAM promotes antitumor immune response in triple negative breast cancer by enhancing CD8+ T cell infiltration.CRTAM 通过增强 CD8+T 细胞浸润促进三阴性乳腺癌的抗肿瘤免疫反应。
Int Immunopharmacol. 2024 Mar 10;129:111625. doi: 10.1016/j.intimp.2024.111625. Epub 2024 Feb 13.
8
Cancer statistics, 2024.2024年癌症统计数据。
CA Cancer J Clin. 2024 Jan-Feb;74(1):12-49. doi: 10.3322/caac.21820. Epub 2024 Jan 17.
9
Methylation signatures as biomarkers for non-invasive early detection of breast cancer: A systematic review of the literature.甲基化特征作为乳腺癌非侵入性早期检测的生物标志物:文献系统综述
Cancer Genet. 2024 Apr;282-283:1-8. doi: 10.1016/j.cancergen.2023.12.003. Epub 2023 Dec 12.
10
Inhibiting KLRB1 expression is associated with impairing cancer immunity and leading to cancer progression and poor prognosis in breast invasive carcinoma patients.抑制 KLRB1 表达与削弱癌症免疫有关,并导致乳腺癌浸润性癌患者癌症进展和预后不良。
Aging (Albany NY). 2023 Nov 20;15(22):13265-13286. doi: 10.18632/aging.205239.